ADAR1 Capital Management, LLC
Q1 2025 13F Holdings
- Locationaustin, TX
- Num holdings
202
- Value ($000)
$538,666
- Date Filed05/15/2025
- Form type13F-HR
- CIK0001940272
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
PTGX PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | $45.44 M | 8 % | 939,669 | ||
BOXX EA SERIES TRUST | ALPHA ARCH 1-3 | 02072L565 | $37.59 M | 7 % | 337,125 | ||
ROIVANT SCIENCES LTD | SHS | G76279101 | $35.15 M | 7 % | 3,483,404 | ||
ZLAB ZAI LAB LTD | ADR | 98887Q104 | $34.00 M | 6 % | 940,858 | ||
IMVT IMMUNOVANT INC | COM | 45258J102 | $16.56 M | 3 % | 968,866 | ||
CYTK CYTOKINETICS INC | COM NEW | 23282W605 | $15.70 M | 3 % | 390,729 | ||
KROS KEROS THERAPEUTICS INC | COM | 492327101 | $15.15 M | 3 % | 1,486,461 | ||
ABIVAX SA | SPONSORED ADS | 00370M103 | $13.81 M | 3 % | 2,210,019 | ||
KRE SPDR SER TR | BLOOMBERG 1-3 MO | 78468R663 | $12.44 M | 2 % | 135,585 | ||
BBIO BRIDGEBIO PHARMA INC | COM | 10806X102 | $11.74 M | 2 % | 339,635 |
Rows Per Page
10
- 10
- 50
- 100